Table 1.
Participant characteristics.
| Sex | 18 M, 20 F |
| Age (years) | 63.0 (8.0) |
| Race | 34 White, 1 Black, 3 Native American |
| Duration of PD (years) | 13.6 (5.0) |
| Months from surgery to participation | 15.5 (8.4) |
| UPDRS Motor Score (OFF stimulation, off PD medication) | 33.9 (11.4) |
| BDI-II Score | 10.0 (5.5); range = 0–21 |
| SSAI Score | 30.4 (7.3); range = 20–45 |
| Psychiatric Medication Type α * | None, n = 15; SSRI, n = 8; SNRI, n = 1; TeCA, n = 3; TCA n = 2; nTCA n = 3; BZD/BZD-like n = 11; Other n = 2 |
Mean (S.D.) shown.
α
Participants may take more than 1 type of psychiatric medication.
*
data not obtained from 2 participants.
BDI-II, Beck Depression Inventory II; SSAI, Spielberger State Anxiety Inventory; SSRI, selective serotonin reuptake inhibitor; SNRI, serotonin and norepinephrine inhibitor; TeCA, tetracyclic antidepressant; TCA, tricyclic antidepressant; nTCA, non-tricyclic antidepressant (bupropion); BZD, benzodiazepine; Other, neudexta and lamotrigine